Prostate - Refresher 2020

This course will review the new data and standard of care for each disease state of prostate cancer. It will start with very low risk disease and go through intermediate risk, high risk, locally advanced, node positive, oligometastatic, and post-operative and will describe what the presenter wou
Category
- Genitourinary Cancer
Format
- Online SA-CME
Credits
- Certificate of Attendance
- SA-CME
Treatment of Metastatic Prostate Cancer: Ready for Primetime? - AM2019

At the PRO session for the AM2018, it was noted that community radiation oncologists are increasingly finding oligometastases as part of their practice or being referred these patients after advanced staging by medical oncology or urology.
Category
- Genitourinary Cancer
Format
- Online SA-CME
Credits
- Certificate of Attendance
- SA-CME
Combining Radiation and Immunotherapy for GU Malignancies: What Works, What Doesn't and What Next - 2020 Annual Meeting

There is significant interest in the potential of combining immunooncology drugs (IO) with radiotherapy (RT).
Category
- Genitourinary Cancer
Format
- Online SA-CME
Credits
- Certificate of Attendance
- SA-CME
Prostate Cancer: Case Based Discussion – 2020 Annual Meeting

This activity will discuss current clinical scenarios in prostate cancer with an expert panel discussing decision points starting from a patient case but expanding to include audience responses, the panel's opinion, and finally discussing the evidence and guidelines for each situation.
Category
- Genitourinary Cancer
Format
- Online SA-CME
Credits
- Certificate of Attendance
- SA-CME
2021 eContouring for Prostate Cancer Case Library

Difficult or controversial clinical cases are presented along with several different management plans favored by select specialists in that field, who provide thought-provoking viewpoints.Contouring Covered:
Category
- Genitourinary Cancer
Format
- eContouring
Credits
- AMA PRA Category 1 Credit™
- Certificate of Attendance
Effects of Exercise During Radiotherapy on Physical Function and Treatment-related Side Effects in Men with Prostate Cancer

IJROBP Journal SA-CME activity for November 1, 2021, provides practitioners with knowledge needed to optimize clinical decision making and prognostic estimation for patients with rectal cancer.
Category
- Palliative Care
- Genitourinary Cancer
Format
- Journal SA-CME
Credits
- Certificate of Attendance
- SA-CME
Four Ways to Decrease Late Toxicity from Pelvic Radiotherapy in Children and Young Adults

This journal activity provides practitioners with the knowledge about the current approaches to reduce pelvic radiotherapy toxicity in young patients.
Category
- Sarcoma/Cutaneous
- Pediatric Cancer
- Gastrointestinal Cancer
- Genitourinary Cancer
- Gynecologic Cancer
Format
- Journal SA-CME
Credits
- Certificate of Attendance
- SA-CME
Genitourinary - Refresher 2021

There is a large volume of new data continuously being released about the optimal management of prostate and other genitourinary cancers. It is essential for practicing radiation oncologists to know the latest data and be able to integrate it into daily practice.
Category
- Genitourinary Cancer
Format
- Online SA-CME
Credits
- Certificate of Attendance
- SA-CME
An Expert Review on the Combination of Relugolix with Definitive Radiation Therapy for Prostate Cancer

This journal activity provides practitioners with the knowledge needed to utilize relugolix in combination with radiation therapy in daily practice.
Category
- Genitourinary Cancer
Format
- Journal SA-CME
Credits
- Certificate of Attendance
- SA-CME
Gray Zone - Postoperative Radiation Therapy in Prostate Cancer: Timing, Duration of Hormonal Treatment and the Use of PSMA PET-CT

The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics. But despite our best efforts, evidence-based medicine cannot provide 1 clear
Category
- Genitourinary Cancer
Format
- Gray Zone
Credits
- AMA PRA Category 1 Credit™